Clinical Trials List
2008-09-01 - 2009-09-30
Phase II
Terminated8
ICD-10E08.00
Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
ICD-10E08.01
Diabetes mellitus due to underlying condition with hyperosmolarity with coma
ICD-10E09.00
Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
ICD-10E09.01
Drug or chemical induced diabetes mellitus with hyperosmolarity with coma
ICD-10E11.00
Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
ICD-10E11.01
Type 2 diabetes mellitus with hyperosmolarity with coma
ICD-10E13.00
Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
ICD-10E13.01
Other specified diabetes mellitus with hyperosmolarity with coma
ICD-9250.20
Diabetes with hyperosmolar coma, Type II [non-insulin dependent type][NIDDM type][adult-onset type ] or unspecified type ,not stated as uncontrolled
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHIH-YUAN WANG CHIH-YUAN WANG Division of Endocrinology
- CHIH-YUAN WANG Division of Endocrinology
- 張恬君 無
- 李弘元 無
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Wen-Cong Lu 無
- Yu-Yao Huang 無
- 劉妙真 無
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 郭銘俊 無
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
320 participants
